7Tabz Ultra Potent 7-OH Tablets feature a premium 7-hydroxymitragynine formulation in a convenient chewable tablet format designed for users seeking concentrated alkaloid content in a compact bottle. Each bottle contains 10 chewable tablets totaling 300mg, providing a portable format that's easy to carry, store, and keep on hand throughout the day.
With 30mg of 7-hydroxymitragynine per tablet, 7Tabz delivers consistent alkaloid content in a chewable format that requires no powders, capsules, or mixing. The durable bottle helps keep tablets protected and organized, making it a practical option for everyday storage, travel, or on-the-go convenience.
30mg Per Tablet: Premium 7-hydroxymitragynine formulation in every chewable tablet.
300mg Total Per Bottle: Ten-tablet bottle delivering concentrated total alkaloid content.
10 Chewable Tablets: Convenient bottle format designed for easy portability and everyday use.
Chewable Format: No powders, capsules, or additional preparation required.
Durable Bottle Packaging: Designed to keep tablets protected, organized, and ready for storage, travel, or everyday carry.
This product is not available for shipment to the following states: Alabama, Arkansas, Connecticut, Florida, Indiana, Louisiana, Wisconsin; or the following counties: Sarasota County (Florida), San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi).
FDA DISCLAIMER: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.
